• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    PRESIDENT AND CEO Shaw Thomas J bought $221 worth of shares (332 units at $0.67), increasing direct ownership by 0.00% to 15,167,588 units (SEC Form 4)

    4/10/25 1:56:27 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care
    Get the next $RVP alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    SHAW THOMAS J

    (Last) (First) (Middle)
    511 LOBO LANE

    (Street)
    LITTLE ELM TX 75068

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    RETRACTABLE TECHNOLOGIES INC [ RVP ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    X Officer (give title below) Other (specify below)
    PRESIDENT AND CEO
    3. Date of Earliest Transaction (Month/Day/Year)
    04/09/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/09/2025 P 332 A $0.667(1) 15,167,588 D
    Common Stock 831,600 I Voting or Investment Control(2)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents weighted average price.
    2. Mr. Shaw has investment power over 500,000 shares as Trustee for the benefit of a family member. Mr. Shaw has voting control over the remainder of the shares pursuant to a voting agreement.
    Remarks:
    The Rule 10b5-1 Plan's date of adoption was August 22, 2024.
    Thomas J. Shaw 04/10/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $RVP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RVP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $RVP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • PRESIDENT AND CEO Shaw Thomas J bought $6,063 worth of shares (8,113 units at $0.75), increasing direct ownership by 0.05% to 15,261,367 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/9/25 3:39:01 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • PRESIDENT AND CEO Shaw Thomas J bought $296 worth of shares (400 units at $0.74), increasing direct ownership by 0.00% to 15,253,254 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/8/25 11:44:13 AM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • PRESIDENT AND CEO Shaw Thomas J bought $3,367 worth of shares (4,500 units at $0.75), increasing direct ownership by 0.03% to 15,252,854 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/7/25 11:46:27 AM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    Leadership Updates

    Live Leadership Updates

    See more
    • Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders

      LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $10,041 and $39,050, respectively. Over the entire accrual period, the dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from October 1, 2020 through date of conversion or December 31, 2020 whichever is applicable. The dividends will be paid on January 29, 2021. All Series I Class B Conv

      1/8/21 2:32:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

      SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

      2/8/23 2:38:31 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

      SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

      5/2/22 4:33:55 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Retractable Technologies Inc. (Amendment)

      SC 13G/A - RETRACTABLE TECHNOLOGIES INC (0000946563) (Subject)

      1/27/22 2:27:52 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Retractable Technologies, Inc. Announces Reduction in Workforce

      Retractable Technologies, Inc. (NYSE:RVP) reports that it has reduced its workforce by approximately 7%. The reduction is expected to save an estimated $1.6 million in annual wages and benefits, or approximately 7.8% of total estimated workforce costs. The expected savings is offset by one-time separation payments of approximately $300 thousand to the affected workers. Approximately 72% of the targeted payroll reduction affects general and administrative functions, with the remainder coming from manufacturing or manufacturing support positions. The move comes as the Company continues to allocate more of its resources to increase its U.S. manufacturing capabilities and reduce reliance on pr

      4/10/25 5:34:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • Retractable Technologies, Inc. Reports Results for 2024

      Retractable Technologies, Inc. (NYSE:RVP) reports the following information relating to the year ended December 31, 2024. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed on March 28, 2025 with the U.S. Securities and Exchange Commission. The Company's revenues for 2024 decreased 24.2%. The Company's revenues were approximately $33.0 million in 2024 as compared to approximately $43.5 million in the prior year. Domestic revenues decreased 15.1% principally due to a decrease in the average selling price as a result of product mix, combined with higher transactional and order fulfillment costs with its distributors. I

      3/28/25 4:58:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

      Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2025 through March 31, 2025. The dividends will be paid on April 21, 2025 to shareholders of record as of the close of business on April 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cathe

      3/28/25 4:53:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    Financials

    Live finance-specific insights

    See more
    • Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

      Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2025 through March 31, 2025. The dividends will be paid on April 21, 2025 to shareholders of record as of the close of business on April 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV cathe

      3/28/25 4:53:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

      Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2024 through December 31, 2024. The dividends will be paid on January 20, 2025 to shareholders of record as of the close of business on January 10, 2025. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and

      12/30/24 12:59:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

      Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2024 through September 30, 2024. The dividends will be paid on October 21, 2024 to shareholders of record as of the close of business on October 10, 2024. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV

      9/30/24 3:46:00 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • PRESIDENT AND CEO Shaw Thomas J bought $6,063 worth of shares (8,113 units at $0.75), increasing direct ownership by 0.05% to 15,261,367 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/9/25 3:39:01 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • PRESIDENT AND CEO Shaw Thomas J bought $296 worth of shares (400 units at $0.74), increasing direct ownership by 0.00% to 15,253,254 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/8/25 11:44:13 AM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • PRESIDENT AND CEO Shaw Thomas J bought $3,367 worth of shares (4,500 units at $0.75), increasing direct ownership by 0.03% to 15,252,854 units (SEC Form 4)

      4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

      5/7/25 11:46:27 AM ET
      $RVP
      Medical/Dental Instruments
      Health Care

    $RVP
    SEC Filings

    See more
    • Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

      4/11/25 2:12:43 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • Retractable Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

      3/28/25 5:02:43 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-K filed by Retractable Technologies Inc.

      10-K - RETRACTABLE TECHNOLOGIES INC (0000946563) (Filer)

      3/28/25 3:13:44 PM ET
      $RVP
      Medical/Dental Instruments
      Health Care